Microbiome In Vivo Gene Editing for Rare Diseases Begins with Umbrella Clinical TrialBy adminNovember 1, 20250 Credit: Blablo101 / iStock / Getty Images Plus It’s been less than six months since the news of Baby KJ…
Microbiome Bristol Myers Squibb Moves Into In Vivo CAR T with $1.5 Billion Orbital BuyBy adminOctober 11, 20250 Credit: Pixelbizz/Getty Images Big pharma Bristol Myers Squibb (BMS) has agreed to acquire RNA biotech Orbital Therapeutics for $1.5 Billion.…
